Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cloak & Dagger: Wyeth Allegedly Disguised Sales Reps as Doctors to Sell Kidney Drug
BNET Pharma
Wednesday, May 26, 2010 - 8:58am
tags:
Wyeth, sales reps, Pfizer, off-label, Rapamune
FDA OKs generic Valtrex from Teva
Bizjournals.com
Wednesday, May 26, 2010 - 8:56am
tags:
FDA, generics, Teva Pharmaceuticals, Valtrex, antivirals, GSK
Nexium, Protonix Linked to Bone Fractures, FDA Says
Bloomberg
Wednesday, May 26, 2010 - 8:54am
tags:
fractures, Nexium, Protonix, Prevacid, AstraZeneca, Takeda, Pfizer, proton pump inhibitors
Bayer’s Nexavar Fails to Win Backing of U.K. Agency
Bloomberg
Wednesday, May 26, 2010 - 8:49am
tags:
Bayer, UK, Nexavar, liver cancer
Tylenol maker pledges quality overhaul
CNN Money
Wednesday, May 26, 2010 - 8:48am
tags:
Tylenol, drug manufacturing, JNJ
Vertex Hepatitis C Drug Cures 75% of Patients
TheStreet.com
Tuesday, May 25, 2010 - 5:24pm
tags:
Vertex Pharmaceuticals, hepatitis C, Telaprevir
Euro Drug Stocks: Safe Haven In Troubled Times
Forbes
Tuesday, May 25, 2010 - 5:12pm
tags:
Europe, drug stocks, Novartis, AstraZeneca, Sanofi, GSK
Genzyme Jumps on FDA Settlement, Approval of Pompe Remedy
Barron's
Tuesday, May 25, 2010 - 5:10pm
tags:
Genzyme, FDA, Pompe disease, Lumizyme
Healthcare Reform Comparative Effectiveness will really mean Comparative Value
Pharmareform
Tuesday, May 25, 2010 - 5:01pm
tags:
healthcare reform, comparative effectiveness
[video] They Just Don't Get Genzyme!
TheStreet.com
Tuesday, May 25, 2010 - 10:53am
tags:
Genzyme, GSK, Vanda, Amarin, Keryx
Drug stocks retreat with broader market
Marketwatch
Tuesday, May 25, 2010 - 10:50am
tags:
drug stocks
A New Program To Educate Docs About Rx Promotion
Pharmalot
Tuesday, May 25, 2010 - 9:22am
tags:
physicians
Astellas to Double Revenue in China, Hire Sales Staff
Bloomberg
Tuesday, May 25, 2010 - 9:02am
tags:
Astellas, hirings, China
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tuesday, May 25, 2010 - 9:02am
tags:
FDA, Novartis, MS, multiple sclerosis, Gilenia
Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales, Suit Claims
BNET Pharma
Tuesday, May 25, 2010 - 9:00am
tags:
Wyeth, Pfizer, lawsuits, off-label, Rapamune
Neurocrine Biosciences shares surge on study
Marketwatch
Tuesday, May 25, 2010 - 8:59am
tags:
Neurocrine, endometriosis, Elagolix
What Investors Think About Alexza Pharmaceuticals
Motley Fool
Tuesday, May 25, 2010 - 8:56am
tags:
Alexza, investors
Teva Targets Roche’s Rituxan in Biosimilar Drug Trial
Bloomberg
Tuesday, May 25, 2010 - 8:52am
tags:
Teva Pharmaceuticals, Roche, Rituxan, biosimilars, generics
New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent
Yahoo
Tuesday, May 25, 2010 - 8:50am
tags:
Abbott Laboratories, stents, Xience
Who Benefits From J&J’s Recalls?
CNBC
Tuesday, May 25, 2010 - 8:49am
tags:
JNJ, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.